Soft Nanocarriers as Antimicrobial Co-Delivery Systems to Combat Resistant Infections

Area of Science:

• Nanomedicine
• Polymer Science
• Drug Delivery

Background:

• Antimicrobial resistance (AMR) is a growing global health crisis requiring novel therapeutic strategies.
• Nanotechnology enables the development of advanced nanocarriers for drug delivery.
• Soft nanocarriers, utilizing polymer and lipid excipients, offer precise control over drug release and targeting.

Purpose of the Study:

• To review the design and applications of nanocarriers as co-delivery systems for combating AMR.
• To highlight the potential of nanocarriers for optimized drug loading, controlled release, and pathogen-specific targeting.
• To discuss challenges and future perspectives in nanocarrier-based antimicrobial therapies.

Main Methods:

• Review of recent literature on nanocarrier systems for multidrug encapsulation.
• Analysis of lipid-based, polymer-based, and hybrid nanocarrier systems.
• Examination of co-delivery strategies for synergistic antimicrobial therapies.

Main Results:

• Nanocarriers can be engineered for optimized drug loading and spatio-temporal control of release.
• Diverse nanocarrier types demonstrate benefits in delivering multiple antimicrobial agents.
• Successful examples of synergistic therapies using nanocarrier co-delivery systems are presented.

Conclusions:

• Nanocarrier co-delivery systems present a promising strategy to overcome AMR.
• Further research is needed to address challenges in controlled release, specificity, and overcoming biological barriers.
• Advanced nanocarrier engineering is crucial for developing effective treatments against resistant infections.